Work

Telavancin Versus Standard Therapy for Treatment of Complicated Skin and Soft-Tissue Infections Due to Gram-Positive Bacteria

Year: 2005

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Clinical Infectious Diseases

DOI: 10.1086/429914

Authors: M. E. Stryjewski, W. D. O'Riordan, W. K. Lau, F. D. Pien, L. M. Dunbar, M. Vallee, V. G. Fowler, V. H. Chu, E. Spencer, S. L. Barriere, M. M. Kitt, C. H. Cabell, G. R. Corey, the FAST Investigator Group

Institutions: Duke University, Duke Medical Center, Duke Clinical Research Institute, Paradise Valley Hospital, St. Francis Medical Center, Straub Medical Center, Louisiana State University, University Medical Center New Orleans, Louisiana State University Health Sciences Center New Orleans, Theravance Biopharma (United States)

Language: English

Topic: Antimicrobial Resistance in Staphylococcus

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Pfizer, National Institutes of Health, Duke Clinical Research Institute

OpenAlex ID: W2127383645

FWCI: 14.98

Cites: 16

Cited by: 173

Related to: 10